»ùÇà ¿äû ¸ñ·Ï¿¡ Ãß°¡
Ç÷¾× ½ºÅ©¸®´× ½ÃÀåÀº 2022-2027³â°£ 11¾ï 7,602¸¸ ´Þ·¯ È®´ëµÇ°í, ¿¹Ãø ±â°£Áß ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)Àº 7.42%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.
Ç÷¾× ½ºÅ©¸®´× ½ÃÀå¿¡ ´ëÇÑ ÀüüÀûÀÎ ºÐ¼®, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ¹× ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ ´ë»óÀ¸·Î ÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ °ÔÀçÇß½À´Ï´Ù.
ÇöÀçÀÇ ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ°ú ¼ºÀå¿äÀÎ, ½ÃÀå ȯ°æ Àüü¿¡ °üÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ¼öÇ÷ ¿ä±¸ Áõ°¡, º¥´õ°£ ÇÕº´¡¤Àμö, ÀÇ·á Áøº¸ µîÀÌ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§
±âÁØ ³âµµ
2022
Á¾·á ³âµµ
2027
¿¹Ãø ±â°£
2023-2027
¼ºÀå ¸ð¸àÅÒ
°¡¼Ó
Àü³â´ëºñ
6.5%
CAGR
7.42%
ÁõºÐ¾×
11¾ï 7,602¸¸ ´Þ·¯
º» Á¶»ç¿¡¼´Â Ç÷¾× ½ºÅ©¸®´× ÇÁ·Î¼¼½º ÀÚµ¿È¸¦ ÇâÈÄ ¸î ³â°£ Ç÷¾× ½ºÅ©¸®´× ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ÁÖ¿äÀÎ Áß Çϳª·Î µé°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Ç÷¾× °¨¿°ÁõÀ̳ª Áúȯ¿¡ ´ëÇÑ ÀÇ½Ä °í¾ç, POC(Point of Care) °Ë»ç Áõ°¡µµ ½ÃÀåÀÇ Å« ¼ö¿ä·Î ¿¬°áµË´Ï´Ù.
¸ñÂ÷
Á¦1Àå ÁÖ¿ä ¿ä¾à
Á¦2Àå ½ÃÀå ±¸µµ
Á¦3Àå ½ÃÀå ±Ô¸ð
½ÃÀåÀÇ Á¤ÀÇ
½ÃÀå ºÎ¹® ºÐ¼®
½ÃÀå ±Ô¸ð(2022³â)
½ÃÀå Àü¸Á(2022-2027³â)
Á¦4Àå ½ÃÀå ±Ô¸ð ½ÇÀû
Ç÷¾× ½ºÅ©¸®´× ¼¼°è ½ÃÀå(2017-2021³â)
ÄÄÆ÷³ÍÆ® ºÎ¹® ºÐ¼®(2017-2021³â)
ÃÖÁ¾»ç¿ëÀÚ ºÎ¹® ºÐ¼®(2017-2021³â)
Áö¿ªº° ºÎ¹® ºÐ¼®(2017-2021³â)
±¹°¡º° ºÎ¹® ºÐ¼®(2017-2021³â)
Á¦5Àå Five Forces ºÐ¼®
Five Forces ¿ä¾à
¹ÙÀ̾îÀÇ ±³¼··Â
°ø±Þ ±â¾÷ÀÇ ±³¼··Â
½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
´ëüǰÀÇ À§Çù
°æÀï À§Çù
½ÃÀå ÇöȲ
Á¦6Àå ½ÃÀå ¼¼ºÐÈ : ÄÄÆ÷³ÍÆ®º°
½ÃÀå ºÎ¹®
ºñ±³ : ÄÄÆ÷³ÍÆ®º°
½Ã¾à ¹× ŰƮ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
±â±â : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
¼ÒÇÁÆ®¿þ¾î ¹× ¼ºñ½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
½ÃÀå ±âȸ : ÄÄÆ÷³ÍÆ®º°
Á¦7Àå ½ÃÀå ¼¼ºÐÈ : ÃÖÁ¾»ç¿ëÀÚº°
½ÃÀå ºÎ¹®
ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
Ç÷¾×ÀºÇà : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
º´¿ø : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°
Á¦8Àå °í°´ »óȲ
Á¦9Àå Áö¿ªº° »óȲ
Áö¿ªº° ¼¼ºÐÈ
Áö¿ªº° ºñ±³
ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø(2022-2027³â)
½ÃÀå ±âȸ : Áö¿ª »óȲº°
Á¦10Àå ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦ ¹× µ¿Çâ
½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
½ÃÀå µ¿Çâ
Á¦11Àå º¥´õ ±¸µµ
°³¿ä
º¥´õ ±¸µµ
È¥¶õ »óȲ
¾÷°è ¸®½ºÅ©
Á¦12Àå º¥´õ ºÐ¼®
´ë»ó º¥´õ
º¥´õÀÇ ½ÃÀå Æ÷Áö¼Å´×
BCAL Diagnostics Ltd.
Becton Dickinson and Co.
Bio Rad Laboratories Inc.
Dr Lal PathLabs Ltd.
Eurofins Scientific SE
F. Hoffmann La Roche Ltd.
Grifols SA
Harley Street Health Checks UK Ltd.
Hemogenomics Pvt. Ltd.
Laboratory Corp. of America Holdings
QuidelOrtho Corp.
Siemens Healthineers AG
Syantra Inc.
Thermo Fisher Scientific Inc.
Vijaya Diagnostic Centre Ltd.
Á¦13Àå ºÎ·Ï
LSH
The blood screening market is forecasted to grow by USD 1,176.02 mn during 2022-2027, accelerating at a CAGR of 7.42% during the forecast period. The report on the blood screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing blood transfusion needs, mergers and acquisitions among vendors, and advancements in medical treatments.
Technavio's blood screening market is segmented as below:
Market Scope
Base Year 2022
End Year 2027
Series Year 2023-2027
Growth Momentum Accelerate
YOY 2023 6.5%
CAGR 7.42%
Incremental Value $1,176.02mn
By Component
Reagents and kits
Instruments
Software and services
By End-user
By Geographical Landscape
North America
Europe
Asia
Rest of World (ROW)
This study identifies the automation in blood screening process as one of the prime reasons driving the blood screening market growth during the next few years. Also, increased awareness of bloodborne infections and diseases and increasing point-of-care testing will lead to sizable demand in the market.
The report on the blood screening market covers the following areas:
Blood screening market sizing
Blood screening market forecast
Blood screening market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood screening market vendors that include Apollo Hospitals Enterprise Ltd., Aster Clinical Lab LLP, BCAL Diagnostics Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Dr Lal PathLabs Ltd., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Grifols SA, Harley Street Health Checks UK Ltd., Hemogenomics Pvt. Ltd., Laboratory Corp. of America Holdings, Mankind Pharma Ltd., Metropolis Healthcare Ltd., QuidelOrtho Corp., Siemens Healthineers AG, Syantra Inc., Thermo Fisher Scientific Inc., and Vijaya Diagnostic Centre Ltd.. Also, the blood screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Component
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global blood screening market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global blood screening market 2017 - 2021 ($ million)
4.2 Component Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Component Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Component
6.1 Market segments
Exhibit 30: Chart on Component - Market share 2022-2027 (%)
Exhibit 31: Data Table on Component - Market share 2022-2027 (%)
6.2 Comparison by Component
Exhibit 32: Chart on Comparison by Component
Exhibit 33: Data Table on Comparison by Component
6.3 Reagents and kits - Market size and forecast 2022-2027
Exhibit 34: Chart on Reagents and kits - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Reagents and kits - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Reagents and kits - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Reagents and kits - Year-over-year growth 2022-2027 (%)
6.4 Instruments - Market size and forecast 2022-2027
Exhibit 38: Chart on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Instruments - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Instruments - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Instruments - Year-over-year growth 2022-2027 (%)
6.5 Software and services - Market size and forecast 2022-2027
Exhibit 42: Chart on Software and services - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Software and services - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Software and services - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Software and services - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Component
Exhibit 46: Market opportunity by Component ($ million)
Exhibit 47: Data Table on Market opportunity by Component ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2022-2027 (%)
Exhibit 49: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Blood bank - Market size and forecast 2022-2027
Exhibit 52: Chart on Blood bank - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Blood bank - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Blood bank - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Blood bank - Year-over-year growth 2022-2027 (%)
7.4 Hospitals - Market size and forecast 2022-2027
Exhibit 56: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 BCAL Diagnostics Ltd.
Exhibit 111: BCAL Diagnostics Ltd. - Overview
Exhibit 112: BCAL Diagnostics Ltd. - Product / Service
Exhibit 113: BCAL Diagnostics Ltd. - Key offerings
12.4 Becton Dickinson and Co.
Exhibit 114: Becton Dickinson and Co. - Overview
Exhibit 115: Becton Dickinson and Co. - Business segments
Exhibit 116: Becton Dickinson and Co. - Key news
Exhibit 117: Becton Dickinson and Co. - Key offerings
Exhibit 118: Becton Dickinson and Co. - Segment focus
12.5 Bio Rad Laboratories Inc.
Exhibit 119: Bio Rad Laboratories Inc. - Overview
Exhibit 120: Bio Rad Laboratories Inc. - Business segments
Exhibit 121: Bio Rad Laboratories Inc. - Key news
Exhibit 122: Bio Rad Laboratories Inc. - Key offerings
Exhibit 123: Bio Rad Laboratories Inc. - Segment focus
12.6 Dr Lal PathLabs Ltd.
Exhibit 124: Dr Lal PathLabs Ltd. - Overview
Exhibit 125: Dr Lal PathLabs Ltd. - Product / Service
Exhibit 126: Dr Lal PathLabs Ltd. - Key offerings
12.7 Eurofins Scientific SE
Exhibit 127: Eurofins Scientific SE - Overview
Exhibit 128: Eurofins Scientific SE - Business segments
Exhibit 129: Eurofins Scientific SE - Key news
Exhibit 130: Eurofins Scientific SE - Key offerings
Exhibit 131: Eurofins Scientific SE - Segment focus
12.8 F. Hoffmann La Roche Ltd.
Exhibit 132: F. Hoffmann La Roche Ltd. - Overview
Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 134: F. Hoffmann La Roche Ltd. - Key news
Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Grifols SA
Exhibit 137: Grifols SA - Overview
Exhibit 138: Grifols SA - Business segments
Exhibit 139: Grifols SA - Key offerings
Exhibit 140: Grifols SA - Segment focus
12.10 Harley Street Health Checks UK Ltd.
Exhibit 141: Harley Street Health Checks UK Ltd. - Overview
Exhibit 142: Harley Street Health Checks UK Ltd. - Product / Service
Exhibit 143: Harley Street Health Checks UK Ltd. - Key offerings
12.11 Hemogenomics Pvt. Ltd.
Exhibit 144: Hemogenomics Pvt. Ltd. - Overview
Exhibit 145: Hemogenomics Pvt. Ltd. - Product / Service
Exhibit 146: Hemogenomics Pvt. Ltd. - Key offerings
12.12 Laboratory Corp. of America Holdings
Exhibit 147: Laboratory Corp. of America Holdings - Overview
Exhibit 148: Laboratory Corp. of America Holdings - Business segments
Exhibit 149: Laboratory Corp. of America Holdings - Key news
Exhibit 150: Laboratory Corp. of America Holdings - Key offerings
Exhibit 151: Laboratory Corp. of America Holdings - Segment focus
12.13 QuidelOrtho Corp.
Exhibit 152: QuidelOrtho Corp. - Overview
Exhibit 153: QuidelOrtho Corp. - Product / Service
Exhibit 154: QuidelOrtho Corp. - Key offerings
12.14 Siemens Healthineers AG
Exhibit 155: Siemens Healthineers AG - Overview
Exhibit 156: Siemens Healthineers AG - Business segments
Exhibit 157: Siemens Healthineers AG - Key news
Exhibit 158: Siemens Healthineers AG - Key offerings
Exhibit 159: Siemens Healthineers AG - Segment focus
12.15 Syantra Inc.
Exhibit 160: Syantra Inc. - Overview
Exhibit 161: Syantra Inc. - Product / Service
Exhibit 162: Syantra Inc. - Key offerings
12.16 Thermo Fisher Scientific Inc.
Exhibit 163: Thermo Fisher Scientific Inc. - Overview
Exhibit 164: Thermo Fisher Scientific Inc. - Business segments
Exhibit 165: Thermo Fisher Scientific Inc. - Key news
Exhibit 166: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 167: Thermo Fisher Scientific Inc. - Segment focus
12.17 Vijaya Diagnostic Centre Ltd.
Exhibit 168: Vijaya Diagnostic Centre Ltd. - Overview
Exhibit 169: Vijaya Diagnostic Centre Ltd. - Business segments
Exhibit 170: Vijaya Diagnostic Centre Ltd. - Key offerings
Exhibit 171: Vijaya Diagnostic Centre Ltd. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations